Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study.

Source:http://linkedlifedata.com/resource/pubmed/id/19364364

Download in:

View as

General Info

Authors

Castells C, Bernardi G, Rossi S, Fiore S, Musella A, Centonze D, Buttari F, Codecà C, Mataluni G

Affiliation

Dipartimento di Neuroscienze, Università Tor Vergata, Rome, Italy.

Abstract

Central neuropathic pain (CNP) is a prevalent and distressing symptom in patients with multiple sclerosis (MS). The anticonvulsant levetiracetam (LEV) has been shown to be efficacious in some types of CNP, but its efficacy in MS-related CNP has not been confirmed.

PMID
19364364

Publication types

Randomized Controlled Trial; Research Support, Non-U.S. Gov't